CD44 and breast cancer: In turn, CD44 adheres to its ligand and leads to the activation of src and phosphorylation of cortactin (Bourguignon et al., 2001; Hill et al., 2006), thus, supporting that Nav1.5 may potentiate the invasion of breast cancer cells by the CD44-src-cortactin signaling axis.